BiotechTube
Home/Revolo Biotherapeutics/Paul Eggleton, Ph.D.
PE

Paul Eggleton, Ph.D.

Vice President, Immunology

Revolo Biotherapeutics

Therapeutic Areas

Autoimmune DiseasesAllergic Diseases

Revolo Biotherapeutics Pipeline

DrugIndicationPhase
'1104Eosinophilic Esophagitis (EoE)Phase 2
'1805Rheumatoid ArthritisPhase 2 (Planned)

Leadership Team at Revolo Biotherapeutics

KB
Kari Brown, M.D.
Chief Medical Officer
DS
David Southwell
Chairman
JD
Jorge De Alba, Ph.D.
Vice President, Discovery and Translational Science
MP
Maria Pittaras, PMP
Vice President, Portfolio and Program Management
FO
Femi Oluboyede
Vice President, Technical Operations, CMC
View full Revolo Biotherapeutics profile